Genprex S-1 IPO Lists on the NASDAQ — Gene Therapy Lung Cancer Treatment Gets Funded – Equities.com
|
Genprex S-1 IPO Lists on the NASDAQ — Gene Therapy Lung Cancer Treatment Gets Funded
Equities.com Genprex has completed their S-1 IPO offering. Their IPO is now listed and trading on the Nasdaq Exchange under the ticker NASDAQ: GNPX. The offering raised $6.5 million at $5/share with a valuation of $58.5 mill before the offering. Prospectus. Note … |
